KAMADA LTD (KMDA) Stock Fundamental Analysis

NASDAQ:KMDA • IL0010941198

8.7 USD
-0.21 (-2.36%)
At close: Feb 27, 2026
8.7 USD
0 (0%)
After Hours: 2/27/2026, 8:14:50 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

KMDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. KMDA has an excellent profitability rating, but there are some minor concerns on its financial health. KMDA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make KMDA a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year KMDA was profitable.
  • In the past year KMDA had a positive cash flow from operations.
  • In multiple years KMDA reported negative net income over the last 5 years.
  • KMDA had a positive operating cash flow in 4 of the past 5 years.
KMDA Yearly Net Income VS EBIT VS OCF VS FCFKMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • The Return On Assets of KMDA (5.42%) is better than 91.55% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.71%, KMDA belongs to the top of the industry, outperforming 91.36% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.66%, KMDA belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 18.14%.
  • The last Return On Invested Capital (6.66%) for KMDA is above the 3 year average (2.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROIC 6.66%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
KMDA Yearly ROA, ROE, ROICKMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • The Profit Margin of KMDA (11.70%) is better than 91.36% of its industry peers.
  • KMDA's Profit Margin has declined in the last couple of years.
  • KMDA's Operating Margin of 15.88% is amongst the best of the industry. KMDA outperforms 93.28% of its industry peers.
  • KMDA's Operating Margin has declined in the last couple of years.
  • KMDA has a better Gross Margin (43.75%) than 74.66% of its industry peers.
  • In the last couple of years the Gross Margin of KMDA has grown nicely.
Industry RankSector Rank
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
KMDA Yearly Profit, Operating, Gross MarginsKMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
  • KMDA has about the same amout of shares outstanding than it did 1 year ago.
  • KMDA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, KMDA has a worse debt to assets ratio.
KMDA Yearly Shares OutstandingKMDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KMDA Yearly Total Debt VS Total AssetsKMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.87 indicates that KMDA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.87, KMDA is in the better half of the industry, outperforming 69.48% of the companies in the same industry.
  • The Debt to FCF ratio of KMDA is 0.61, which is an excellent value as it means it would take KMDA, only 0.61 years of fcf income to pay off all of its debts.
  • KMDA has a Debt to FCF ratio of 0.61. This is amongst the best in the industry. KMDA outperforms 94.63% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
  • The Debt to Equity ratio of KMDA (0.04) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Altman-Z 3.87
ROIC/WACC0.78
WACC8.5%
KMDA Yearly LT Debt VS Equity VS FCFKMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that KMDA has no problem at all paying its short term obligations.
  • KMDA has a Current ratio of 4.03. This is comparable to the rest of the industry: KMDA outperforms 47.98% of its industry peers.
  • KMDA has a Quick Ratio of 2.24. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.24, KMDA is not doing good in the industry: 71.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 2.24
KMDA Yearly Current Assets VS Current LiabilitesKMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
  • Measured over the past years, KMDA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.60% on average per year.
  • The Revenue has grown by 10.36% in the past year. This is quite good.
  • The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%

3.2 Future

  • KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.28% yearly.
  • Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.57% on average per year.
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KMDA Yearly Revenue VS EstimatesKMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
KMDA Yearly EPS VS EstimatesKMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 24.17, KMDA is valued on the expensive side.
  • 92.90% of the companies in the same industry are more expensive than KMDA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of KMDA to the average of the S&P500 Index (27.10), we can say KMDA is valued inline with the index average.
  • KMDA is valuated rather expensively with a Price/Forward Earnings ratio of 18.15.
  • 93.86% of the companies in the same industry are more expensive than KMDA, based on the Price/Forward Earnings ratio.
  • KMDA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.17
Fwd PE 18.15
KMDA Price Earnings VS Forward Price EarningsKMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 96.93% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, KMDA is valued cheaply inside the industry as 94.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 26.87
EV/EBITDA 10.5
KMDA Per share dataKMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of KMDA may justify a higher PE ratio.
  • A more expensive valuation may be justified as KMDA's earnings are expected to grow with 31.28% in the coming years.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • KMDA has a Yearly Dividend Yield of 2.30%.
  • Compared to an average industry Dividend Yield of 1.17, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.66% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, KMDA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

  • KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KMDA Yearly Dividends per shareKMDA Yearly Dividends per shareYearly Dividends per share 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%
KMDA Yearly Income VS Free CF VS DividendKMDA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

KAMADA LTD

NASDAQ:KMDA (2/27/2026, 8:14:50 PM)

After market: 8.7 0 (0%)

8.7

-0.21 (-2.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-18
Inst Owners11.42%
Inst Owner Change-10.37%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap501.82M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (52.41%)
Short Float %0.25%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)0%
PT rev (3m)-11.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 24.17
Fwd PE 18.15
P/S 2.87
P/FCF 26.87
P/OCF 17.35
P/B 1.89
P/tB 2.14
EV/EBITDA 10.5
EPS(TTM)0.36
EY4.14%
EPS(NY)0.48
Fwd EY5.51%
FCF(TTM)0.32
FCFY3.72%
OCF(TTM)0.5
OCFY5.76%
SpS3.03
BVpS4.6
TBVpS4.07
PEG (NY)0.55
PEG (5Y)N/A
Graham Number6.1
Profitability
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROCE 8.43%
ROIC 6.66%
ROICexc 8.52%
ROICexgc 9.66%
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
FCFM 10.68%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Debt/EBITDA 0.22
Cap/Depr 66.53%
Cap/Sales 5.86%
Interest Coverage 35.82
Cash Conversion 67%
Profit Quality 91.33%
Current Ratio 4.03
Quick Ratio 2.24
Altman-Z 3.87
F-Score7
WACC8.5%
ROIC/WACC0.78
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
EBIT growth 1Y56.45%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y937.39%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y334.95%
OCF growth 3YN/A
OCF growth 5Y11.54%

KAMADA LTD / KMDA FAQ

Can you provide the ChartMill fundamental rating for KAMADA LTD?

ChartMill assigns a fundamental rating of 6 / 10 to KMDA.


What is the valuation status for KMDA stock?

ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.


Can you provide the profitability details for KAMADA LTD?

KAMADA LTD (KMDA) has a profitability rating of 7 / 10.


How financially healthy is KAMADA LTD?

The financial health rating of KAMADA LTD (KMDA) is 6 / 10.